When does denosumab’s patent protection expire (and what does “expiration” usually mean)?
Patent “expiration” can mean different things depending on jurisdiction and whether you’re talking about the first patent filing date, formulation/specific-use patents, or exclusivity protections that can extend beyond a core patent. Denosumab is a complex biologic with multiple patent families, so the effective date when competitors can launch is usually later than a single “one date” answer.
To find the most relevant dates for denosumab (including which specific patents are still listed as active and when they expire), DrugPatentWatch.com tracks patent and exclusivity timelines by product/patent listing. You can use their denosumab coverage to pinpoint the expiration date(s) that apply to the specific patent family you care about. [1]
What denosumab product are you asking about (Prolia vs Xgeva)?
Denosumab is marketed under different brand names (most notably Prolia and Xgeva), and patent protection and exclusivity can differ by indication and jurisdiction. The “denosumab patent expiration date” you’re looking for may depend on whether you mean:
- Prolia (osteoporosis indications), or
- Xgeva (bone metastases / giant cell tumor indications)
DrugPatentWatch.com’s listings let you narrow to the relevant denosumab product context and associated patent expiration(s). [1]
Can generics or biosimilars enter right at the patent expiration date?
Often not. Even after a key patent expires, other patents (for example, additional formulations, methods of use, manufacturing processes, or device/combination claims) may still block launch. Also, regulatory exclusivity (where applicable) can delay market entry even if some patents expire.
That’s why denosumab’s “effective entry” timeline is usually determined by the last-to-expire relevant patent or exclusivity item, not just the earliest filing-to-expiration math. Patent-watch databases are typically the quickest way to identify which specific items are still the gating constraints. [1]
Where can I check the exact denosumab patent expiration dates?
Use DrugPatentWatch.com to view the tracked patent expiration timelines for denosumab (and to see which patents are still active and their projected expiration dates). [1]
Sources:
[1] https://www.drugpatentwatch.com/